Small Molecules

28 Apr 2007 INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia
28 Apr 2007 FDA approves once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray for treatment of seasonal and year-round allergy symptoms in adults and children as young as two years
28 Apr 2007 Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
27 Apr 2007 Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
27 Apr 2007 Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
27 Apr 2007 SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
27 Apr 2007 4SC AG: 60 Patients in Phase IIa Clinical Trial
27 Apr 2007 Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
26 Apr 2007 Exelixis Files IND Application for XL765
26 Apr 2007 XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
26 Apr 2007 MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
26 Apr 2007 Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
26 Apr 2007 Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
26 Apr 2007 ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
26 Apr 2007 Vanda Pharmaceuticals Initiates Phase II Clinical Trial for VSF-173 in Excessive Sleepiness
26 Apr 2007 Ceragenix Commences Second in Series of Clinical Trials
26 Apr 2007 SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With MP470
26 Apr 2007 BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
26 Apr 2007 Resverlogix Announces Milestone ApoA-l/HDL Proof-of-Concept Data
25 Apr 2007 NeuroSearch and GlaxoSmithKline initiate second clinical Phase II study with NS2359 in depression
25 Apr 2007 TopoTarget announces next Phase II clinical placebo controlled trial with Avugane(TM) in acne vulgaris
25 Apr 2007 Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntington's Disease
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Lexicon Advances LX1031 for Irritable Bowel Syndrome into Phase 1b Clinical Trial
25 Apr 2007 Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up